Study of gut bacteria in stem cell transplant patients
Part of Blood & lymphatic, Infections clinical trials.
This study looks at a specific type of bacteria in the gut of patients who have had a stem cell transplant. It aims to understand how these bacteria affect the risk of infection, which could help improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have received a stem cell transplant from a donor (allogeneic).
- Your transplant has successfully started producing new blood cells (no graft failure).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood sugar problems in people who have had a stem cell transplant from a donor. It may help doctors learn how to better manage or prevent diabetes after a transplant.
This trial tests whether a special herbal treatment applied to the skin can help prevent infections around the bottom that are caused by diarrhea after a stem cell transplant. It may be an option for people who are getting a transplant for the first time.
This study tracks patients who have had or are planning to have a stem cell transplant. It helps doctors learn more about long-term outcomes and improve care for future patients.
This study looks at changes in your gut bacteria (microbiome) around the time of stem cell transplant. The goal is to understand how these bacteria relate to transplant outcomes, which may help doctors improve care in the future.
This study looks at the bacteria in your gut (microbiome) after an organ transplant to understand how they might affect your health. By participating, you help researchers learn more about transplant recovery and long-term well-being.
This trial tests whether giving a transplant of healthy gut bacteria (fecal microbiota transplant) before a stem cell transplant can improve outcomes for people with certain blood cancers or bone marrow disorders.
Hear when a new Allogeneic Hematopoietic Stem Cell Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.